Member Feature

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Troubled Waters for Endava's Investors The corporate waters churn as Endava plc (NYSE:DAVA) finds itself slapped with a securities class action lawsuit. This legal storm rises amid talks of delayed financials and whispers of potential accounting frippery, sending shockwaves that slashed the company's stock price by a bone-rattling 25% on September 22, 2026. Now, investors...

The Federal Home Loan Bank of Boston dropped their third-quarter results for 2026 like a hot smokestack, and let me tell you, it's a mixed bag of cautious optimism and steady progression. It's essentially proof that slow and steady might just win the race—or at least keep you in the running. Stable and Steady Headway Taking a peek under the hood, FHLBank Boston made a...

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Yazan Al Homsi Backs Canadian Innovation Every once in a while, you see a move in the market that feels bigger than the numbers on the page. That's what this $500,000 from Yazan Al Homsi into Arcanus Aerial Systems does. Al Homsi, a UAE-based investor with a solid pedigree, decided to pump half a million bucks into Arcanus just as it's setting down roots in Canadian soil...

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Emerging AI Risks and Protective Measures AI in financial spaces is like walking a tightrope, there's potential but caution is crucial. Enter Enigmata, diving headfirst into this arena by shaking hands with the Finovifi Marketplace. Their aim? To bolster AI's promise without letting sensitive data slip through the cracks. Sentinel: A New Guard for Sensitive Data Let's not...

When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....

Pickleball's Power Play: The Media Move Out of the blue, the world of niche sports finds its hub. Beyond The Bounce steps up to the plate by roping in pickleball’s own Zane Navratil. The hype’s not in the spin here—this is serious business. The company plans to push the boundaries of the sport into mainstream media, or at least give it a decent shot. Zane Navratil:...

Overview of Altamira Therapeutics' Progress Altamira Therapeutics Ltd. (Nasdaq: CYTO) is excited to share significant advancements in its RNA delivery technology along with a business update and its financial results for the first half of 2024. The company has made notable progress, particularly focusing on innovative methods to deliver RNA to extrahepatic tissues....

Amy Green: A Leader in Sustainable Fashion Amy Green, the innovative CEO and Founder of The Green Vision, is set to receive the prestigious 2024 ECO Award at Fashion 4 Development's (F4D) 12th Annual First Ladies Luncheon. This prominent occasion will coincide with the start of the United Nations General Assembly, drawing attention to the urgent discussions surrounding...

Enhancing Access to Private Market Investments The Investment Company Institute (ICI) is thrilled about recent developments that encourage broader access to private market investments for American investors. This initiative marks a significant step towards empowering everyday Americans to explore various investment options usually reserved for institutional investors. The...

Class Action Lawsuit Filed Against Kings FLC Inc. A significant class action lawsuit has been initiated by the prominent labor and employment law firms, Zakay Law Group, APLC and JCL Law Firm, APC, alleging that Kings FLC Inc. has failed to uphold essential labor laws. Understanding the Allegations The lawsuit points out that Kings FLC Inc. has allegedly not compensated...

Understanding the Legal Landscape for Aehr Test Systems Investors In the world of investments, staying informed is crucial for protecting your rights and interests. Recently, investors in Aehr Test Systems, Inc. find themselves in a significant legal situation that demands attention. The DJS Law Group is reminding these investors about a class action lawsuit against Aehr....